Fulcrum Capital’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,200
| Closed | -$230K | – | 113 |
|
|
2024
Q2 | $230K | Hold |
1,200
| – | – | 0.05% | 102 |
|
|
2024
Q1 | $238K | Sell |
1,200
-269
| -18% | -$53.3K | 0.06% | 107 |
|
|
2023
Q4 | $253K | Sell |
1,469
-186
| -11% | -$32K | 0.07% | 100 |
|
|
2023
Q3 | $245K | Hold |
1,655
| – | – | 0.07% | 93 |
|
|
2023
Q2 | $362K | Hold |
1,655
| – | – | 0.1% | 81 |
|
|
2023
Q1 | $362K | Sell |
1,655
-185
| -10% | -$40.5K | 0.1% | 79 |
|
|
2022
Q4 | $383K | Hold |
1,840
| – | – | 0.11% | 76 |
|
|
2022
Q3 | $402K | Hold |
1,840
| – | – | 0.12% | 64 |
|
|
2022
Q2 | $386K | Hold |
1,840
| – | – | 0.12% | 59 |
|
|
2022
Q1 | $446K | Sell |
1,840
-1,053
| -36% | -$255K | 0.12% | 55 |
|
|
2021
Q4 | $754K | Hold |
2,893
| – | – | 0.16% | 54 |
|
|
2021
Q3 | $762K | Hold |
2,893
| – | – | 0.18% | 54 |
|
|
2021
Q2 | $713K | Hold |
2,893
| – | – | 0.18% | 47 |
|
|
2021
Q1 | $561K | Hold |
2,893
| – | – | 0.16% | 52 |
|
|
2020
Q4 | $615K | Sell |
2,893
-43
| -1% | -$9.14K | 0.18% | 43 |
|
|
2020
Q3 | $503K | Hold |
2,936
| – | – | 0.18% | 44 |
|
|
2020
Q2 | $564K | Buy |
2,936
+43
| +1% | +$8.26K | 0.21% | 41 |
|
|
2020
Q1 | $426K | Sell |
2,893
-607
| -17% | -$89.4K | 0.19% | 44 |
|
|
2019
Q4 | $542K | Hold |
3,500
| – | – | 0.17% | 47 |
|
|
2019
Q3 | $473K | Buy |
+3,500
| New | +$473K | 0.16% | 50 |
|